Novel pharmacological approach for the prevention of multidrug resistance (MDR) in a human leukemia cell line
Author:
Funder
University of Central Punjab
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference53 articles.
1. Single-cell analysis of K562 cells: an imatinib-resistant subpopulation is adherent and has upregulated expression of BCR-ABL mRNA and protein;Karimiani;Exp. Hematol.,2014
2. Mathematical modelling of miRNA mediated BCR. ABL protein regulation in chronic myeloid leukaemia vis-a-vis therapeutic strategies;Verma;Integr. Biol.,2013
3. California Cancer Facts & Figures (2017);American Cancer Society CDoPH,2017
4. Spectrum of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia from India with suspected resistance to imatinib-mutations are rare and have different distributions;Markose;Leuk. Lymphoma,2009
5. Management of chronic myeloid leukemia patients resistant to tyrosine kinase inhibitors treatment;Wieczorek;Biomark. Insights,2015
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel betulin derivatives as multidrug reversal agents targeting P-glycoprotein;Scientific Reports;2024-01-02
2. Analysis of the Inhibitory Effect of hsa-miR-145-5p and hsa-miR-203a-5p on Imatinib-Resistant K562 Cells by GC/MS Metabolomics Method;Journal of the American Society for Mass Spectrometry;2023-09-14
3. Synthesis and molecular-based analysis of betulin derivatives as strong multidrug reversal agents targeting P-glycoprotein;2023-05-24
4. Enhanced imatinib uptake through influx transporters and its quantification based on LC-MS/MS in human leukemic cells;2023-05-23
5. miR-145-5p and miR-203a-5p overcome imatinib resistance in myelogenous leukemic cells through metabolic reprogramming;Indian Journal of Biochemistry and Biophysics;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3